vs

Side-by-side financial comparison of Calumet, Inc. (CLMT) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Calumet, Inc. is the larger business by last-quarter revenue ($1.0B vs $568.5M, roughly 1.8× Real Brokerage Inc). Real Brokerage Inc runs the higher net margin — -0.1% vs -3.6%, a 3.5% gap on every dollar of revenue. Calumet, Inc. produced more free cash flow last quarter ($103.8M vs $8.4M).

Calumet, Inc. is a U.S.-headquartered specialty products firm that manufactures and distributes high-value hydrocarbon and specialty chemical products. Its offerings include specialty oils, lubricants, waxes, and renewable fuel solutions, serving industrial, consumer, and transportation segments across North America.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

CLMT vs REAX — Head-to-Head

Bigger by revenue
CLMT
CLMT
1.8× larger
CLMT
$1.0B
$568.5M
REAX
Higher net margin
REAX
REAX
3.5% more per $
REAX
-0.1%
-3.6%
CLMT
More free cash flow
CLMT
CLMT
$95.4M more FCF
CLMT
$103.8M
$8.4M
REAX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLMT
CLMT
REAX
REAX
Revenue
$1.0B
$568.5M
Net Profit
$-37.3M
$-447.0K
Gross Margin
-0.3%
7.9%
Operating Margin
-6.2%
-0.1%
Net Margin
-3.6%
-0.1%
Revenue YoY
52.6%
Net Profit YoY
82.7%
EPS (diluted)
$-0.43
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLMT
CLMT
REAX
REAX
Q4 25
$1.0B
Q3 25
$1.1B
$568.5M
Q2 25
$1.0B
$540.7M
Q1 25
$993.9M
$354.0M
Q3 24
$1.1B
$372.5M
Q2 24
$1.1B
Q1 24
$200.7M
Net Profit
CLMT
CLMT
REAX
REAX
Q4 25
$-37.3M
Q3 25
$313.4M
$-447.0K
Q2 25
$-147.9M
$1.5M
Q1 25
$-162.0M
$-5.0M
Q3 24
$-100.6M
$-2.6M
Q2 24
$-39.1M
Q1 24
$-16.1M
Gross Margin
CLMT
CLMT
REAX
REAX
Q4 25
-0.3%
Q3 25
34.7%
7.9%
Q2 25
-4.2%
8.9%
Q1 25
-8.2%
9.6%
Q3 24
0.4%
8.6%
Q2 24
5.6%
Q1 24
10.3%
Operating Margin
CLMT
CLMT
REAX
REAX
Q4 25
-6.2%
Q3 25
30.0%
-0.1%
Q2 25
-9.8%
0.3%
Q1 25
-4.9%
-1.5%
Q3 24
-5.2%
-0.7%
Q2 24
0.5%
Q1 24
-7.8%
Net Margin
CLMT
CLMT
REAX
REAX
Q4 25
-3.6%
Q3 25
29.1%
-0.1%
Q2 25
-14.4%
0.3%
Q1 25
-16.3%
-1.4%
Q3 24
-9.1%
-0.7%
Q2 24
-3.4%
Q1 24
-8.0%
EPS (diluted)
CLMT
CLMT
REAX
REAX
Q4 25
$-0.43
Q3 25
$3.61
$0.00
Q2 25
$-1.70
$0.01
Q1 25
$-1.87
$-0.02
Q3 24
$-1.18
$-0.01
Q2 24
$-0.48
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLMT
CLMT
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$125.1M
$38.7M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$-732.7M
$53.6M
Total Assets
$2.7B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLMT
CLMT
REAX
REAX
Q4 25
$125.1M
Q3 25
$94.6M
$38.7M
Q2 25
$110.6M
$49.7M
Q1 25
$123.4M
$24.7M
Q3 24
$34.6M
$22.6M
Q2 24
$7.0M
Q1 24
$20.1M
Total Debt
CLMT
CLMT
REAX
REAX
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.3B
Q3 24
$1.7B
Q2 24
Q1 24
Stockholders' Equity
CLMT
CLMT
REAX
REAX
Q4 25
$-732.7M
Q3 25
$-695.3M
$53.6M
Q2 25
$-1.0B
$49.2M
Q1 25
$-862.3M
$32.8M
Q3 24
$-672.2M
$29.8M
Q2 24
$-566.4M
Q1 24
$25.6M
Total Assets
CLMT
CLMT
REAX
REAX
Q4 25
$2.7B
Q3 25
$2.7B
$145.2M
Q2 25
$2.8B
$149.4M
Q1 25
$2.8B
$100.5M
Q3 24
$2.6B
$102.5M
Q2 24
$100
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLMT
CLMT
REAX
REAX
Operating Cash FlowLast quarter
$116.5M
$8.8M
Free Cash FlowOCF − Capex
$103.8M
$8.4M
FCF MarginFCF / Revenue
10.0%
1.5%
Capex IntensityCapex / Revenue
1.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$56.6M
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLMT
CLMT
REAX
REAX
Q4 25
$116.5M
Q3 25
$23.5M
$8.8M
Q2 25
$-1.8M
$41.0M
Q1 25
$-29.3M
$15.9M
Q3 24
$-15.5M
$7.2M
Q2 24
Q1 24
$21.5M
Free Cash Flow
CLMT
CLMT
REAX
REAX
Q4 25
$103.8M
Q3 25
$15.1M
$8.4M
Q2 25
$-15.4M
$40.8M
Q1 25
$-46.9M
$15.7M
Q3 24
$-32.2M
$6.8M
Q2 24
Q1 24
$21.4M
FCF Margin
CLMT
CLMT
REAX
REAX
Q4 25
10.0%
Q3 25
1.4%
1.5%
Q2 25
-1.5%
7.5%
Q1 25
-4.7%
4.4%
Q3 24
-2.9%
1.8%
Q2 24
Q1 24
10.7%
Capex Intensity
CLMT
CLMT
REAX
REAX
Q4 25
1.2%
Q3 25
0.8%
0.1%
Q2 25
1.3%
0.0%
Q1 25
1.8%
0.1%
Q3 24
1.5%
0.1%
Q2 24
2.2%
Q1 24
0.0%
Cash Conversion
CLMT
CLMT
REAX
REAX
Q4 25
Q3 25
0.07×
Q2 25
27.13×
Q1 25
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLMT
CLMT

Specialty Products And Solutions$675.9M65%
Montana Renewables$294.2M28%
Performance Brands$68.5M7%

REAX
REAX

Segment breakdown not available.

Related Comparisons